Is Ozempic Safe During Pregnancy?
No, Ozempic (semaglutide) should not be used during pregnancy. Animal studies show it causes fetal harm, including dose-dependent embryo-fetal deaths, structural abnormalities like microphthalmia and scoliosis, and reduced offspring growth in rats and rabbits at exposures below human levels.[1][2] Human data is limited, but the drug's label states potential risk to the fetus, advising discontinuation at least 2 months before planned pregnancy due to its long half-life (about 1 week).[1] The FDA pregnancy category is Not Assigned, with a black box warning absent but clear contraindication based on reproductive toxicity data.[3]
Real-world reports include rare cases of congenital anomalies in exposed pregnancies, though causality is unproven due to small numbers and confounding factors like maternal obesity or diabetes.[4]
What About Breastfeeding?
Ozempic is not recommended while breastfeeding. It is unknown if semaglutide passes into human milk, but it does appear in rat milk at levels similar to maternal plasma (up to 4% of dose).[1][2] Effects on breastfed infants—such as gastrointestinal issues or growth impacts—are unstudied, so the risk outweighs unknown benefits.[3] Providers suggest pumping and discarding milk or using formula if needed.
Why the Restrictions?
Semaglutide mimics GLP-1, altering gut hormone signaling that affects fetal development and placental function in animal models. It crosses the placenta in primates, reaching fetal blood at half maternal levels.[2] No adequate human trials exist; post-marketing surveillance continues via registries like the Semaglutide Pregnancy Registry.[1]
Alternatives for Diabetes Management in Pregnancy or Breastfeeding
Insulin is the standard for type 2 diabetes in pregnancy—safe, effective, and non-teratogenic.[5] Metformin is often used off-label post-first trimester with monitoring.[5] For breastfeeding, insulin and metformin are preferred as they have established safety profiles.[3] Weight loss drugs like older GLP-1s (exenatide) lack data but are similarly cautioned.[2] Consult an endocrinologist for glycemic control without Ozempic.
What If Exposure Happens Accidentally?
Stop Ozempic immediately and monitor for fetal growth via ultrasound. Report to the pregnancy registry (1-877-452-3252) or FDA MedWatch for outcomes tracking.[1] No specific antidote exists; supportive care only.
Sources
[1]: Ozempic Prescribing Information (Novo Nordisk)
[2]: FDA Drug Safety Communication on GLP-1 Agonists
[3]: Drugs.com - Ozempic Pregnancy and Breastfeeding Warnings
[4]: PubMed - Semaglutide Pregnancy Outcomes Review
[5]: ADA Standards of Care in Diabetes - Pregnancy